Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study

Cynthia S. Bonhof, Floortje Mols, M. Caroline Vos, Johanna M. A. Pijnenborg, Dorry Boll, Gerard Vreugdenhil, Nicole P. M. Ezendam, Lonneke V. van de Poll-Franse

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)455-463
Number of pages9
JournalGynecologic Oncology
Volume149
Issue number3
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • SURVIVORSHIP CARE PLAN
  • EVERY 3 WEEKS
  • REPORTED OUTCOMES
  • 1ST-LINE CHEMOTHERAPY
  • QUESTIONNAIRE MODULE
  • PROFILES REGISTRY
  • CLINICAL-PRACTICE
  • RANDOMIZED-TRIAL
  • ONCOLOGY-GROUP
  • ROGY CARE

Cite this

Bonhof, C. S., Mols, F., Vos, M. C., Pijnenborg, J. M. A., Boll, D., Vreugdenhil, G., Ezendam, N. P. M., & van de Poll-Franse, L. V. (2018). Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study. Gynecologic Oncology, 149(3), 455-463. https://doi.org/10.1016/j.ygyno.2018.03.052